Vaccine Therapy Compared With Interferon Alfa in Treating Patients With Stage III Melanoma
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Vaccines made from a person's melanoma cells may make the body build an immune
response to kill tumor cells. Interferon alfa may interfere with the growth of the cancer
cells.
PURPOSE: Randomized phase III trial to compare the effectiveness of melanoma vaccine with
that of interferon alfa-2b in treating patients who have stage III melanoma that has spread
to regional lymph nodes following surgery.